Patents by Inventor David J. Heal

David J. Heal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating sexual dysfunction
    Patent number: 6376554
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate), including individual enantiomers and racemates thereof, is used for treating sexual dysfunction.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: April 23, 2002
    Assignee: Knoll Pharmaceutical Company
    Inventors: Sharon C. Cheetham, David J. Heal
  • Method of treating eating disorders
    Patent number: 6365633
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for treating eating disorders, such as anorexia nervosa, bulimia nervosa, weight-gain after smoking cessation, snacking or binge eating.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: April 2, 2002
    Assignee: Knoll Pharmaceutical Company
    Inventors: Sharon C. Cheetham, David J. Heal, Carl M. Mendel, Timothy B. Seaton, Steve P. Weinstein
  • Method of treating sleep apnoea
    Patent number: 6365631
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl, including individual enantiomers or racemates thereof, (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride optionally in the form of its monohydrate) is used for treating sleeping disorders including sleep apnoea and snoring.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: April 2, 2002
    Assignee: Knoll Pharmaceutical Company
    Inventors: Sharon C. Cheetham, David J. Heal, Carl M. Mendel, Timothy B. Seaton, Steve P. Weinstein, Anton Safer
  • Method of treating anxiety disorders
    Patent number: 6355685
    Abstract: A compound of formula I or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate), including individual enantiomers and racemates thereof, is used for treating anxiety disorders.
    Type: Grant
    Filed: March 17, 2000
    Date of Patent: March 12, 2002
    Assignee: Knoll Pharmaceutical Company
    Inventors: Sharon C. Cheetham, David J. Heal, Graham P. Luscombe